Results 271 to 280 of about 297,465 (360)

Association of preoperative controlling nutritional status score with clinical outcomes among surgical patients with esophageal cancer: a meta-analysis [PDF]

Yanli Ji, Lei Wang, Xiaoli Mei, Erliang Zheng, Lin Lin, Mei Yang   +5 more
openalex   +1 more source

Active surveillance for clinical complete response after neoadjuvant treatment of locally advanced esophageal cancer. [PDF]

J Thorac Dis
Hoeppner J, Nimczewski F.
europepmc   +1 more source

From endoscopy to surgery: a translational perspective on early esophageal cancer management. [PDF]

Front Med (Lausanne)
Pan MX, Sun LN, Su ML, Xiu YL.
europepmc   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

Re-irradiation for recurrent esophageal cancer: clinical benefit, survival outcomes, and toxicity profile. [PDF]

Clin Transl Radiat Oncol
Mattioli C, van Werkhoven LA, Loi M, Nuyttens JJ.   +3 more
europepmc   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, EarlyView.
What's New? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Prognostic value of nutritional risk index in esophageal cancer: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Liu ZY, Liu B.
europepmc   +1 more source

Quality of life in cancer patients at the end of radiotherapy compared to a general population sample in Germany

International Journal of Cancer, EarlyView.
What's New? While radiotherapy is an essential component of oncology treatment, it remains unclear how the quality of life of treated patients compares to that of the general population. This pooled secondary analysis of two cross‐sectional studies conducted in Germany reveals existing gaps in global quality of life between the general population and ...
Alexander Fabian, Alexander Rühle, Gregor Liegl, Justus Domschikowski, Maike Trommer, Simone Ferdinandus, Jan‐Niklas Becker, Georg Wurschi, Simon Boeke, Mathias Sonnhoff, Christoph Grott, Lukas Käsmann, Melanie Schneider, Sandra Freitag‐Wolf, Nils H. Nicolay, David Krug, Sandra Nolte   +16 more
wiley   +1 more source

The clinical value of CT and MRI in preoperative TNM staging of esophageal cancer. [PDF]

Front Med (Lausanne)
Zhao W, Huang J, Chen Y, Lu J, Hu W.
europepmc   +1 more source

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival

International Journal of Cancer, EarlyView.
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven, Steven C. Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I. van Berge Henegouwen, Peter S. N. van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W. M. van Laarhoven   +9 more
wiley   +1 more source